- Home
- BLRX vs GRFX Comparison
BLRX vs GRFX Comparison
Compare BLRX & GRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- GRFX
- Stock Information
- Founded
- BLRX 2003
- GRFX 1981
- Country
- BLRX Israel
- GRFX Hong Kong
- Employees
- BLRX N/A
- GRFX N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- GRFX
- Sector
- BLRX Health Care
- GRFX
- Exchange
- BLRX Nasdaq
- GRFX Nasdaq
- Market Cap
- BLRX 17.3M
- GRFX 18.1M
- IPO Year
- BLRX 2011
- GRFX N/A
- Fundamental
- Price
- BLRX $0.10
- GRFX $0.31
- Analyst Decision
- BLRX Strong Buy
- GRFX Hold
- Analyst Count
- BLRX 2
- GRFX 1
- Target Price
- BLRX $5.50
- GRFX N/A
- AVG Volume (30 Days)
- BLRX 18.8M
- GRFX 1.9M
- Earning Date
- BLRX 11-25-2024
- GRFX 01-01-0001
- Dividend Yield
- BLRX N/A
- GRFX N/A
- EPS Growth
- BLRX N/A
- GRFX N/A
- EPS
- BLRX N/A
- GRFX N/A
- Revenue
- BLRX $21,991,000.00
- GRFX $30,019,108.00
- Revenue This Year
- BLRX N/A
- GRFX N/A
- Revenue Next Year
- BLRX N/A
- GRFX N/A
- P/E Ratio
- BLRX N/A
- GRFX N/A
- Revenue Growth
- BLRX N/A
- GRFX N/A
- 52 Week Low
- BLRX $0.08
- GRFX $0.14
- 52 Week High
- BLRX $1.44
- GRFX $0.94
- Technical
- Relative Strength Index (RSI)
- BLRX 28.83
- GRFX 53.62
- Support Level
- BLRX $0.23
- GRFX $0.28
- Resistance Level
- BLRX $0.14
- GRFX $0.34
- Average True Range (ATR)
- BLRX 0.03
- GRFX 0.08
- MACD
- BLRX -0.00
- GRFX -0.00
- Stochastic Oscillator
- BLRX 6.93
- GRFX 16.03
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About GRFX Graphex Group Limited each representing 20
Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.